Results 51 to 60 of about 298,673 (357)

Impact of frailty on outcomes and readmissions after transcatheter and surgical aortic valve replacement in a national cohortCentral MessagePerspective

JTCVS Open
Objective: We examined the effect of frailty on in-hospital mortality, readmission rates, and hospitalization costs after transcatheter and surgical aortic valve replacement in a population-level cohort.
Travis J. Miles, MD, Christopher T. Ryan, MD, Katie J. Hogan, PhD, Bhavesh S. Sayal, BS, Christopher B. Sylvester, MD, PhD, Todd K. Rosengart, MD, Joseph S. Coselli, MD, Marc R. Moon, MD, Ravi K. Ghanta, MD, Subhasis Chatterjee, MD   +9 more
doaj   +1 more source

Relationship between the serum GDF-15 concentration and muscle function in female patients receiving aortic valve replacement (TAVR, SAVR): Comparison with healthy elderly female subjects

International Journal of Cardiology: Heart & Vasculature, 2022
Purpose: Sarcopenia is closely associated with postoperative prognosis in patients undergoing cardiovascular surgery. Growth differentiation factor (GDF)-15 is involved in the pathogenesis of cardiovascular disease.
Taira Fukuda, Toshiaki Nakajima, Hiroko Yazawa, Suguru Hirose, Jun Yokomachi, Takashi Kato, Riichi Nishikawa, Nobuo Koshiji, Michiaki Tokura, Takahisa Nasuno, Setsu Nishino, Syotaro Obi, Ikuko Shibasaki, Tomoaki Kanaya, Fumitaka Nakamura, Hirotsugu Fukuda, Shichiro Abe, Masashi Sakuma, Shigeru Toyoda   +18 more
doaj   +1 more source

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement.

New England Journal of Medicine, 2019
BACKGROUND Whether the direct factor Xa inhibitor rivaroxaban can prevent thromboembolic events after transcatheter aortic-valve replacement (TAVR) is unclear.
G. Dangas, J. Tijssen, J. Wöhrle, L. Søndergaard, M. Gilard, H. Möllmann, R. Makkar, H. Herrmann, G. Giustino, S. Baldus, O. De Backer, Ana H C Guimarães, L. Gullestad, A. Kini, D. von Lewinski, M. Mack, R. Moreno, U. Schäfer, J. Seeger, D. Tchétché, K. Thomitzek, M. Valgimigli, P. Vranckx, R. Welsh, P. Wildgoose, A. Volkl, A. Zazula, R. van Amsterdam, R. Mehran, S. Windecker   +29 more
semanticscholar   +1 more source

Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes.

European Heart Journal, 2020
AIMS We sought to perform a head-to-head comparison of contemporary 30-day outcomes and readmissions between valve-in-valve transcatheter aortic valve replacement (VIV-TAVR) patients and a matched cohort of high-risk reoperative surgical aortic valve ...
S. Hirji, E. Percy, C. Zogg, Alexandra Malarczyk, M. Harloff, F. Yazdchi, T. Kaneko   +6 more
semanticscholar   +1 more source

Valve‐in‐valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement: A systematic review and meta‐analysis

Journal of cardiac surgery, 2021
With the growing contemporary use of bioprosthetic valves, whose limited long‐term durability has been well‐documented, an increase in the need for reintervention is expected.
Adham Ahmed, Kenneth H Levy
semanticscholar   +1 more source

Transcatheter Aortic Valve Implantation in Dialysis Patients [PDF]

, 2012
Background/Aims: Transcatheter aortic valve implantation (TAVI) has emerged as a new therapeutic option for high-risk patients. However, dialysis patients were excluded from all previous studies.
Baglin A, Braun J, Bryg RJ, Christian Kupatt, Cribier A, Edwards FH, Gerhard Steinbeck, Herzog CA, Iung B, Leon MB, London GM, Lucke JC, Maher ER, Matthias Wessely, Michael Fischereder, Philipp Lange, Rodes-Cabau J, Simon Rau, Smith CR, Stinebaugh J, Straumann E, Tanaka K, Ulf Schönermarck, Urena P, Varadarajan P, Varma R   +25 more
core   +1 more source

Awake Surgical Mitral Valve Repair after Transcatheter Aortic Valve Replacement

The Thoracic & Cardiovascular Surgeon Reports, 2021
Transcatheter aortic valve replacement has become a popular choice for cases with severe aortic stenosis. However, when severe mitral regurgitation is comorbid in high-risk patients with severe aortic stenosis, therapeutic options must be weighed for ...
Aina Hirofuji, Hirotsugu Kanda, Yuya Kitani, Hiroyuki Kamiya   +3 more
doaj   +1 more source

On the Modeling of Patient-Specific Transcatheter Aortic Valve Replacement: A Fluid–Structure Interaction Approach

Cardiovascular Engineering and Technology, 2019
Giulia Luraghi, Francesco Migliavacca, Alberto García‐González, Claudio Chiastra, Alexia Rossi, Davide Cao, Giulio Stefanini, José Félix Rodríguez Matas   +7 more
openalex   +3 more sources

Transcatheter aortic valve implantation vs. surgical aortic valve replacement for treatment of symptomatic severe aortic stenosis: an updated meta-analysis.

European Heart Journal, 2019
AIMS Owing to new evidence from randomized controlled trials (RCTs) in low-risk patients with severe aortic stenosis, we compared the collective safety and efficacy of transcatheter aortic valve implantation (TAVI) vs.
G. Siontis, P. Overtchouk, T. Cahill, T. Modine, B. Prendergast, F. Praz, T. Pilgrim, T. Petrinic, A. Nikolakopoulou, G. Salanti, L. Søndergaard, S. Verma, P. Jüni, S. Windecker   +13 more
semanticscholar   +1 more source

Outcomes of Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve Disease

Circulation, 2020
Supplemental Digital Content is available in the text. Background: Patients with bicuspid aortic valve (AV) stenosis were excluded from the pivotal evaluations of transcatheter AV replacement (TAVR) devices.
Sharif A. Halim, Fred H. Edwards, David Dai, Zhuokai Li, Michael J. Mack, David R. Holmes, E. Tuzcu, V. Thourani, J. Harrison, J. M. Brennan   +9 more
semanticscholar   +1 more source